← SynDRA
ZOLMITRIPTAN
SynDRA canonical compound SYN0004352 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | HTR1F |
|---|
| Mechanism of action | Serotonin receptor agonist |
|---|
| Indication | migraine headache |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- HTR1B
- HTR1D
- HTR1A
- HTR1F
- HTR1E
- Adra2a
- Adra2b
- Adra2c
- Drd1
- Drd2
Mechanisms of action (all sources)
- Serotonin receptor agonist
- HTR1B AGONIST
- Serotonin 1b (5-HT1b) receptor agonist
- HTR1D AGONIST
- Serotonin 1d (5-HT1d) receptor agonist
- HTR1B MODULATOR
- HTR1D MODULATOR
Drug classes
- Neurotransmitter Agents
- Serotonin 5-HT1 Receptor Agonists
- Serotonin Agents
- Serotonin Receptor Agonists
- Serotonin 1b Receptor Agonists
- Serotonin 1d Receptor Agonists
- Serotonin-1b and Serotonin-1d Receptor Agonist
ATC classes
- N02C · ANTIMIGRAINE PREPARATIONS
Cross-references
Synonyms
- zipton
- zominat
- zomigoro
- 311C90
- Cvt-427
- 311-C-90
- NSC-760383
- Zomig
- Zomig-zmt
- AscoTop
- Flezol
- Zolmitriptane
- Zolmitriptanum
- Zomigon
- Zolmitriptan RapidFilm
- Zolmitriptan [USAN]
- Zomig Nasal Spray
- Zomig-ZMT
- AscoTop (TN)
- BW-311C90
- KS-5072
- Zomig (TN)
- Zomigon (TN)
- Zomigoro (TN)
- Zomig, Zomigon, AscoTopand, Zomigoro, Zolmitriptan
- (4S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one
- (4S)-4-[[3-(2-dimethylaminoethyl)-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one
- (S)-4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone
- (S)-4-((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)-2-oxazolidinone
- (S)-4-[3-(2-Dimethylamino-ethyl)-1H-indol-5-ylmethyl]-oxazolidin-2-one
- (S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone
- 4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone
- 4-[[3-(2-dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one
- Zomigoro
- Zomig ZMT
- C16H21N3O2
- (S)-4-((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)methyl)oxazolidin-2-one
- NSC 760383
Reported adverse events
- Asthenia
- Nausea
- Somnolence
- Dizziness
- Headache
- Pain
- Hypersensitivity
- Serotonin syndrome
- Vasospasm
- Dysphagia
- Arrhythmia
- Dry mouth
Look up ZOLMITRIPTAN in the interactive SynDRA portal →